Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog

• Published in: Regulatory peptides 1998-09, Vol.75, p.55-70
• Main Authors: Malmström, Rickard E., Hökfelt, Tomas, Björkman, Jan-Arne, Nihlén, Carina, Byström, Mona, Ekstrand, A.Jonas, Lundberg, Jan M.
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Animals; Arginine - analogs & derivatives; Arginine - metabolism; Base Sequence; BIBP 3226; Cloning, Molecular; DNA Primers - genetics; DNA, Complementary - genetics; Dogs; Humans; In Situ Hybridization; Kidney; Kidney - metabolism; Medicin och hälsovetenskap; Molecular Sequence Data; Peptide YY - pharmacology; Receptors, Neuropeptide Y - classification; Receptors, Neuropeptide Y - genetics; Receptors, Neuropeptide Y - metabolism; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - genetics; RNA, Messenger - metabolism; Sequence Homology, Amino Acid; Species Specificity; Spleen; Spleen - metabolism; SR 120107A; Swine; Vasoconstriction; Vasoconstriction - drug effects
• ISSN: 0167-0115; 1873-1686
• DOI: 10.1016/S0167-0115(98)00053-6

Cloning with subsequent in vitro and in vivo characterization of vascular neuropeptide Y (NPY) receptor subtypes in porcine and canine peripheral tissues was performed. RT-PCR with Y 1 and Y 2 receptor-specific primers, indicated expression of Y 1 receptors in both kidney and spleen of dog and pig, and expression of Y 2 receptors in pig spleen. In pig kidney, expression of Y 1 receptor mRNA was located to intrarenal arteries, as demonstrated with in situ hybridization using human probes. The cloned and sequenced canine Y 1, porcine Y 1 and Y 2 receptors revealed high homologies to previously characterized mammalian NPY receptors. Membrane and autoradiographic receptor-binding studies showed specific high-affinity binding sites for the purported Y 1-selective radioligands 125I-[Leu 31Pro 34]peptide YY (PYY) and 3H-BIBP 3226 in dog spleen, and for the putative Y 2-selective 125I-PYY(3–36) in dog and pig spleen. In the pig in vivo, [Leu 31Pro 34]PYY, administered i.v., evoked vasoconstriction in spleen and kidney, actions that were potently inhibited by the non-peptide Y 1 receptor antagonist SR 120107A. In contrast, PYY(3–36) evoked vasoconstriction only in spleen and this effect was not influenced by SR 120107A. NPY evoked renal and splenic vasoconstriction in the dog in vivo, vascular responses that were inhibited by both BIBP 3226 and SR 120107A. Furthermore, the Y 1 receptor agonist [Leu 31Pro 34]NPY also caused vasoconstriction in dog kidney and spleen, whereas the putative Y 2 agonist N-acetyl[Leu 28Leu 31]NPY(24–36) evoked no such vascular responses. It is concluded that the pig spleen is likely to contain Y 1 and Y 2 receptors, both involved in splenic vasoconstriction. In contrast, the Y 1 receptor seems to be the sole vascular NPY receptor subtype in pig kidney. Moreover, Y 1 receptors predominate in dog spleen and kidney. Furthermore, the cloned canine Y 1 receptor and the porcine Y 1 and Y 2 receptors show great homologies to, and possess ligand requirement profiles in accordance with, the human forms.